Repare Therapeutics (RPTX) PT Lowered to $45 at Stifel, Analyst Believes RP-3500 Data Could Improve with More Follow-up Time
Tweet Send to a Friend
Stifel analyst Benjamin J. Burnett lowered the price target on Repare Therapeutics (NASDAQ: RPTX) to $45.00 (from $47.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
